Literature DB >> 16934875

Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.

Maria Ban, David Booth, Robert Heard, Graeme Stewart, An Goris, Koen Vandenbroeck, Bénédicte Dubois, Mikko Laaksonen, Jorma Ilonen, Mehdi Alizadeh, Gilles Edan, Marie Claude Babron, David Brassat, Michael Clanet, Isabelle Cournu-Rebeix, Bertrand Fontaine, Gilbert Semana, Rene Goedde, Jorg Epplen, Alexandra Weber, Carmen Infante-Duarte, Frauke Zipp, Cecilia Rajda, Krisztina Bencsik, László Vécsei, Shirley Heggarty, Colin Graham, Stanley Hawkins, Maria Liguori, Patricia Momigliano-Richiardi, Domenico Caputo, Luigi M E Grimaldi, Maurizio Leone, Luca Massacesi, Clara Milanese, Marco Salvetti, Giovani Savettieri, Maria Trojano, Bartosz Bielecki, Marcin P Mycko, Krzysztof Selmaj, Monica Santos, Patricia Maciel, Clara Pereira, Ana Silva, Berta Martins Silva, Francesca Coraddu, Maria Giovanna Marrosu, Eva Akesson, Jan Hillert, Pameli Datta, Annette Oturai, Hanne F Harbo, Anne Spurkland, Robert Goertsches, Pablo Villoslada, Mefkure Eraksoy, Anke Hensiek, Alastair Compston, Efrosini Setakis, Julia Gray, Tai Wai Yeo, Stephen Sawcer.   

Abstract

By combining all the data available from the Genetic Analysis of Multiple sclerosis in EuropeanS (GAMES) project, we have been able to identify 17 microsatellite markers showing consistent evidence for apparent association. As might be expected five of these markers map within the Major Histocompatibility Complex (MHC) and are in LD with HLA-DRB1. Individual genotyping of the 12 non-MHC markers confirmed association for three of them--D11S1986, D19S552 and D20S894. Association mapping across the candidate genes implicated by these markers in 937 UK trio families revealed modestly associated haplotypes in JAG1 (p=0.019) on chromosome 20p12.2 and POU2AF1 (p=0.003) on chromosome 11q23.1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934875     DOI: 10.1016/j.jneuroim.2006.06.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.

Authors:  Marcel P Stoop; Vaibhav Singh; Lennard J Dekker; Mark K Titulaer; Christoph Stingl; Peter C Burgers; Peter A E Sillevis Smitt; Rogier Q Hintzen; Theo M Luider
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

2.  A C-terminal acidic domain regulates degradation of the transcriptional coactivator Bob1.

Authors:  John M Lindner; Christina S F Wong; Andreas Möller; Peter J Nielsen
Journal:  Mol Cell Biol       Date:  2013-09-23       Impact factor: 4.272

Review 3.  The immunogenetics of multiple sclerosis.

Authors:  Arne Svejgaard
Journal:  Immunogenetics       Date:  2008-05-07       Impact factor: 2.846

4.  Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission.

Authors:  Ariel T Arthur; Patricia J Armati; Chris Bye; Robert N S Heard; Graeme J Stewart; John D Pollard; David R Booth
Journal:  BMC Med Genet       Date:  2008-03-19       Impact factor: 2.103

5.  Systems approach to the study of brain damage in the very preterm newborn.

Authors:  Alan Leviton; Pierre Gressens; Olaf Wolkenhauer; Olaf Dammann
Journal:  Front Syst Neurosci       Date:  2015-04-14

Review 6.  Remyelination Therapy in Multiple Sclerosis.

Authors:  Danielle E Harlow; Justin M Honce; Augusto A Miravalle
Journal:  Front Neurol       Date:  2015-12-10       Impact factor: 4.003

7.  Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes.

Authors:  Heejoo Kim; Jelena Perovanovic; Arvind Shakya; Zuolian Shen; Cody N German; Andrea Ibarra; Jillian L Jafek; Nai-Pin Lin; Brian D Evavold; Danny H-C Chou; Peter E Jensen; Xiao He; Dean Tantin
Journal:  J Exp Med       Date:  2021-03-01       Impact factor: 14.307

8.  A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases.

Authors:  Ricardo Palacios; Joaquin Goni; Ivan Martinez-Forero; Jaime Iranzo; Jorge Sepulcre; Ignacio Melero; Pablo Villoslada
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

Review 9.  Notch signaling and T-helper cells in EAE/MS.

Authors:  Ribal Bassil; William Orent; Wassim Elyaman
Journal:  Clin Dev Immunol       Date:  2013-11-14

10.  Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population.

Authors:  Masoomeh Rahmanian; Mohammad Kargar
Journal:  Iran Red Crescent Med J       Date:  2014-12-27       Impact factor: 0.611

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.